论文信息 - The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease - 字舞流文

The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease

Nicholas W. Wood | Matthew J. Farrer | Vincenzo Bonifati | Thomas Gasser | John Hardy | Giuseppe De Michele | Giuseppe Meco | Ben A. Oostra | Maria Martinez | Monique M.B. Breteler | M. Farrer | S. Lincoln | J. Hardy | M. Breteler | B. Oostra | A. Dürr | A. Brice | N. Wood | Maria Martinez | T. Gasser | G. Michele | G. Meco | V. Bonifati | Alexis Brice | Sarah Lincoln | Alexandra Dürr | B. Harhangi | B. Bereznai | Benjamin Bereznai | J. Vaughan | B.Sanjay Harhangi | Jenny R. Vaughan | B. Oostra | J. Hardy

[1] Y. Agid,et al. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. , 1999, Human molecular genetics.

[2] M. Farrer,et al. Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease. , 1999, Neuroreport.

[3] M. Farrer,et al. A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor. , 1999, Human molecular genetics.

[4] Georg Auburger,et al. The ubiquitin pathway in Parkinson's disease , 1998, Nature.

[5] C. Marsden,et al. The α‐synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: A study of 230 European cases , 1998 .

[6] M. Farrer,et al. ANTIBODIES TO NON-AMYLOID COMPONENT OF PLAQUES (NACP) SPECIFICALLY LABEL LEWY BODIES AND LEWY NEURITES, BUT NOT OTHER INCLUSIONS IN NEURODEGENERATIVE DISEASES , 1998 .

[7] S. Minoshima,et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[8] K D Wilkinson,et al. Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. , 1998, Biochemistry.

[9] Olaf Riess,et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[10] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.

[11] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[12] J. Dartigues,et al. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[13] A Hofman,et al. Prevalence of Parkinson's disease in the elderly , 1995, Neurology.

[14] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[15] M. Fox,et al. The gene for human neurone specific ubiquitin C‐terminal hydrolase(UCHLl, PGP9.5) maps to chromosome 4p14 , 1991, Annals of human genetics.

[16] C. Marsden,et al. A clinical and genetic study of familial Parkinson's disease , 1991, Movement disorders : official journal of the Movement Disorder Society.

[17] J. Lowe,et al. Ubiquitin carboxyl‐terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases , 1990, The Journal of pathology.

[18] M. Tabaton,et al. Selective presence of ubiquitin in intracellular inclusions. , 1989, The American journal of pathology.

[19] Y. Ihara,et al. Ubiquitin is a component of paired helical filaments in Alzheimer's disease. , 1987, Science.